跳至主要内容
临床试验/NCT07474441
NCT07474441已完成不适用

Early Coronary Angiography Associates With Survival Benefit and Longer Time to Initiation of Renal Replacement Therapy in Patients With Advanced Chronic Kidney Disease and Acute Coronary Syndrome: A Survival Analysis

Chulalongkorn University0 个研究点目标入组 139 人开始时间: 2017年1月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
139
主要终点
Renal replacement therapy initiation

研究概览

简要总结

This is the retrospective study regarding the association of invasive coronary angiography and time to renal replacement therapy initiation and mortality in patients with chronic kidney disease stage 4-5 who develop acute coronary syndrome.

详细描述

Electronic medical records of adult patients admitted with ACS, by the recorded diagnosis code, between 1 January 2017 and 31 December 2021 at King Chulalongkorn Memorial Hospital, Thailand, were retrospectively reviewed. Eligible patients should have concurrent advanced stage CKD, defined as an eGFR less than 30 mL/min/1.73 m² calculated by the 2021 CKD-EPI creatinine equation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Advanced stage CKD, defined as an eGFR less than 30 mL/min/1.73 m²
  • Diagnosis with ACS, by the recorded diagnosis code, between 1 January 2017 and 31 December 2021 at King Chulalongkorn Memorial Hospital

排除标准

  • Received maintenance dialysis or kidney transplantation before admission
  • Cardiogenic shock or cardiac arrest
  • Prior PCI or CABG within 12 months
  • Recently diagnosed with ACS within 2 months
  • Had a limited life expectancy due to non-cardiovascular disease
  • Pregnant.

研究组 & 干预措施

Conservative management

Medical management without coronary angiography

Early coronary angiography

Recieve coronary angiography within 24 hours of admission

干预措施: coronary angiography (Procedure)

Delayed coronary angiography

Recieve coronary angiography later than 24 hours of admission

干预措施: coronary angiography (Procedure)

结局指标

主要结局

Renal replacement therapy initiation

时间窗: Until 31 December 2021

Renal replacement therapy initiation

次要结局

  • All-cause mortality(Until 31 Dec 2021)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Thana Thongsricome, MD

Dr.

Chulalongkorn University

相似试验